Skip to main content
. 2022 Apr 7;2022(4):CD007216. doi: 10.1002/14651858.CD007216.pub2

Comparison 3. Tacrolimus versus beclometasone.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 Achievement of clinical remission 1 88 Risk Ratio (M‐H, Random, 95% CI) 1.07 [0.60, 1.88]
3.2 Clinical improvement 1 88 Risk Ratio (M‐H, Random, 95% CI) 1.00 [0.66, 1.52]
3.3 Serious adverse events 1 88 Risk Ratio (M‐H, Random, 95% CI) 3.00 [0.13, 71.70]
3.4 Total adverse events 1 88 Risk Ratio (M‐H, Random, 95% CI) 1.50 [0.88, 2.55]